| Random forest analysis of untargeted metabolomics data suggests increased use of omega fatty acid oxidation pathway in drosophila melanogaster larvae fed a medium chain fatty … VH Oza, JK Aicher, LK Reed Metabolites 9 (1), 5, 2018 | 12 | 2018 |
| CINmetrics: an R package for analyzing copy number aberrations as a measure of chromosomal instability VH Oza, JL Fisher, R Darji, BN Lasseigne PeerJ 11, e15244, 2023 | 6 | 2023 |
| Quantifying transcriptome diversity: a review EF Jones, A Haldar, VH Oza, BN Lasseigne Briefings in Functional Genomics 23 (2), 83-94, 2024 | 5 | 2024 |
| Ten simple rules for using public biological data for your research VH Oza, JH Whitlock, EJ Wilk, A Uno-Antonison, B Wilk, M Gajapathy, ... PLOS Computational Biology 19 (1), e1010749, 2023 | 5 | 2023 |
| Cell‐type‐specific gene expression and regulation in the cerebral cortex and kidney of atypical Setbp1S858R Schinzel Giedion Syndrome mice JH Whitlock, TM Soelter, TC Howton, EJ Wilk, VH Oza, BN Lasseigne Journal of Cellular and Molecular Medicine 27 (22), 3565-3577, 2023 | 3 | 2023 |
| Altered glia-neuron communication in Alzheimer’s Disease affects WNT, p53, and NFkB Signaling determined by snRNA-seq TM Soelter, TC Howton, AD Clark, VH Oza, BN Lasseigne Cell Communication and Signaling: CCS 22, 2024 | 1 | 2024 |
| Inferring chromosomal instability from copy number aberrations as a measure of chromosomal instability across human cancers S Taluri, VH Oza, TM Soelter, JL Fisher, BN Lasseigne Cancer Reports 6 (12), e1902, 2023 | 1 | 2023 |
| Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion EJ Wilk, TC Howton, JL Fisher, VH Oza, RT Brownlee, KC McPherson, ... Molecular Medicine 29 (1), 67, 2023 | 1 | 2023 |
| Quantifying variability in gene expression profiles using transcriptome and isoform diversity E Jones, A Haldar, V Oza, B Lasseigne Preprints, 2023 | 1 | 2023 |
| CINmetrics: An R package for chromosomal instability analysis VH Oza, JL Fisher, R Darji, BN Lasseigne bioRxiv, 2021.11. 15.467294, 2021 | 1 | 2021 |
| Signature reversion of three disease‐associated gene signatures prioritizes cancer drug repurposing candidates JL Fisher, EJ Wilk, VH Oza, SE Gary, TC Howton, VL Flanary, AD Clark, ... FEBS Open bio 14 (5), 803-830, 2024 | | 2024 |
| CoSIA: an R Bioconductor package for CrOss Species Investigation and Analysis A Haldar, VH Oza, NS DeVoss, AD Clark, BN Lasseigne Bioinformatics 39 (12), btad759, 2023 | | 2023 |
| Constructing a Graphical Model of the Drosophila melanogaster Metabolome VH Oza The University of Alabama, 2020 | | 2020 |
